Latest Regulatory Milestones News

Meteoric Resources has cleared a major regulatory hurdle with the approval of its Preliminary Environmental License for the Caldeira Rare Earths Project, enabling the company to progress towards construction and first production targeted for 2028. The company also commissioned its pilot plant, producing its first batches of rare earth carbonate.

Megado Minerals is poised to advance its Iberian Copper Project with investigation permits expected early 2026, setting the stage for airborne geophysics and maiden drilling. Meanwhile, the company maintains strong positions in Canadian lithium and gold assets.

Emerald Resources NL has announced a significant update to its Dingo Range Gold Project in Western Australia, increasing its mineral resource to 1.41 million ounces of gold and securing full mining permits ahead of planned development in 2026.

EMVision Medical Devices reports strong clinical trial progress for its portable brain scanners, backed by solid cash reserves and milestone grant funding.

Argenica Therapeutics has unveiled compelling AI-driven results confirming ARG-007’s significant benefits in severe acute ischemic stroke patients, setting the stage for a precision-focused Phase 2b trial.

Javelin Minerals is advancing towards gold production at its Eureka Gold Project in Western Australia, targeting a June 2026 start under a new partnership with MEGA Resources. The company also identifies promising exploration targets at Coogee and maintains a solid cash position to support development.

Magnetic Resources NL has upgraded its Lady Julie Gold Project resource to 2.24 million ounces, with over 80% now in the Indicated category, positioning the company closer to development readiness. The LJN4 deposit remains a standout as one of Western Australia’s largest and highest-grade undeveloped open pit gold deposits.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

The Swedish Government has formally approved the detailed zoning plan for Talga Group’s Nunasvaara South Graphite Mine, clearing a major regulatory hurdle and advancing the Vittangi Anode Project towards commercial production.

Santana Minerals has cleared key regulatory and operational hurdles for its Bendigo-Ophir Gold Project in New Zealand, with a 30-year mining permit granted and strong drilling results boosting project prospects ahead of targeted mid-2026 construction.

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.